Chemistry:Indoxyl sulfate
| |
| Names | |
|---|---|
| Preferred IUPAC name
1H-Indol-3-yl hydrogen sulfate | |
| Other names
3-Indoxylsulfate; 3-Indoxylsulfuric acid; Indol-3-yl sulfate
| |
| Identifiers | |
3D model (JSmol)
|
|
| ChEBI | |
| ChEMBL | |
| ChemSpider | |
| DrugBank | |
PubChem CID
|
|
| UNII | |
| |
| |
| Properties | |
| C8H7NO4S | |
| Molar mass | 213.21 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
| Infobox references | |
Indoxyl sulfate, also known as 3-indoxylsulfate and 3-indoxylsulfuric acid, is a metabolite of dietary L-tryptophan that acts as a cardiotoxin and uremic toxin.[1][2][3] High concentrations of indoxyl sulfate in blood plasma are known to be associated with the development and progression of chronic kidney disease and vascular disease in humans.[1][2][3] As a uremic toxin, it stimulates glomerular sclerosis and renal interstitial fibrosis.[1][2]
Biosynthesis
Indoxyl sulfate is a metabolite of dietary L-tryptophan that is synthesized through the following metabolic pathway:[3][4][5]
Indole is produced from L-tryptophan in the human intestine via tryptophanase-expressing gastrointestinal bacteria.[3] Indoxyl is produced from indole via enzyme-mediated hydroxylation in the liver;[3][4] in vitro experiments with rat and human liver microsomes suggest that the CYP450 enzyme CYP2E1 hydroxylates indole into indoxyl.[4] Subsequently, indoxyl is converted into indoxyl sulfate by sulfotransferase enzymes in the liver;[4][5] based upon in vitro experiments with recombinant human sulfotransferases, SULT1A1 appears to be the primary sulfotransferase enzyme involved in the conversion of indoxyl into indoxyl sulfate.[5] {{Annotated image 4 | image = Microbiota-derived 3-Indolepropionic acid-notext.svg | link = Commons:File:Microbiota-derived 3-Indolepropionic acid.svg | header = Tryptophan metabolism by human gastrointestinal microbiota ( ) | header_align = center | header_background = #F0F8FF | align = center | image-width = 600 | image-left = 0 | image-top = 10 | width = 580 | height = 470 | alt = Tryptophan metabolism diagram | caption = {{{caption|This diagram shows the biosynthesis of bioactive compounds (indole and certain other derivatives) from by bacteria in the gut.[3] Indole is produced from tryptophan by bacteria that express tryptophanase.[3] Clostridium sporogenes metabolizes tryptophan into indole and subsequently 3-indolepropionic acid (IPA),[6] a highly potent neuroprotective antioxidant that scavenges hydroxyl radicals.[3][7][8] IPA binds to the pregnane X receptor (PXR) in intestinal cells, thereby facilitating mucosal homeostasis and barrier function.[3] Following absorption from the intestine and distribution to the brain, IPA confers a neuroprotective effect against cerebral ischemia and Alzheimer's disease.[3] Lactobacillus species metabolize tryptophan into {{when pagename is|Indole-3-carboxaldehyde=indole-3-carboxaldehyde|other=indole-3-aldehyde}} (I3A) which acts on the aryl hydrocarbon receptor (AhR) in intestinal immune cells, in turn increasing interleukin-22 (IL-22) production.[3] Indole itself triggers the secretion of glucagon-like peptide-1 (GLP-1) in intestinal L cells and acts as a ligand for AhR.[3] Indole can also be metabolized by the liver into other=Indoxyl sulfate]], a compound that is toxic in high concentrations and associated with vascular disease and renal dysfunction.[3] AST-120 (activated charcoal), an intestinal sorbent that is [[Oral administrat[[Physics:taken by mouth,Chemistry:Adsorption|adsorbs i]]ndole, in turn decreasing the concentration of indoxyl sulfate in blood plasma.[3] }}} | annot-font-size = 14 | annot-text-align = left | annotations =
expressing
bacteria
immune
cells
↓Activation of glial cells and astrocytes
↓4-Hydroxy-2-nonenal levels
↓DNA damage
–Antioxidant
–Inhibits β-amyloid fibril formation
↑IL-22 production
↑Oxidative stress
↑Smooth muscle cell proliferation
↑Aortic wall thickness and calcification
↑Renal dysfunction
–Uremic toxin
}}
Clinical significance
Occasionally in urinary tract infections, bacteria produce indoxyl phosphatase which splits indoxyl sulfate forming indigo and indirubin creating dramatic purple urine.[9] Indoxyl sulfate is also a product of indole metabolism, which is produced from tryptophan by intestinal flora, such as Escherichia coli.[10]
References
- ↑ 1.0 1.1 1.2 "Indoxyl sulfate". Human Metabolome Database – Version 4.0. 23 October 2017. http://www.hmdb.ca/metabolites/HMDB00682. Retrieved 15 November 2017.
- ↑ 2.0 2.1 2.2 "Indoxyl sulfate". PubChem Compound. United States National Library of Medicine – National Center for Biotechnology Information. 11 November 2017. https://pubchem.ncbi.nlm.nih.gov/compound/10258. Retrieved 15 November 2017.
- ↑ 3.00 3.01 3.02 3.03 3.04 3.05 3.06 3.07 3.08 3.09 3.10 3.11 3.12 3.13 "Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions". Genome Med 8 (1): 46. April 2016. doi:10.1186/s13073-016-0296-x. PMID 27102537. "Lactobacillus spp. convert tryptophan to indole-3-aldehyde (I3A) through unidentified enzymes [125]. Clostridium sporogenes convert tryptophan to IPA [6], likely via a tryptophan deaminase. ... IPA also potently scavenges hydroxyl radicals".
Table 2: Microbial metabolites: their synthesis, mechanisms of action, and effects on health and disease
Figure 1: Molecular mechanisms of action of indole and its metabolites on host physiology and disease - ↑ 4.0 4.1 4.2 4.3 "Hepatic microsomal metabolism of indole to indoxyl, a precursor of indoxyl sulfate". European Journal of Drug Metabolism and Pharmacokinetics 26 (4): 235–40. 2001. doi:10.1007/bf03226377. PMID 11808865.
- ↑ 5.0 5.1 5.2 "Sulfation of indoxyl by human and rat aryl (phenol) sulfotransferases to form indoxyl sulfate". European Journal of Drug Metabolism and Pharmacokinetics 27 (2): 135–40. 2002. doi:10.1007/bf03190428. PMID 12064372.
- ↑ "Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites". Proc. Natl. Acad. Sci. U.S.A. 106 (10): 3698–3703. March 2009. doi:10.1073/pnas.0812874106. PMID 19234110. "Production of IPA was shown to be completely dependent on the presence of gut microflora and could be established by colonization with the bacterium Clostridium sporogenes.".
IPA metabolism diagram - ↑ "3-Indolepropionic acid". University of Alberta. http://www.hmdb.ca/metabolites/HMDB02302. Retrieved 12 June 2018. "Indole-3-propionate (IPA), a deamination product of tryptophan formed by symbiotic bacteria in the gastrointestinal tract of mammals and birds. 3-Indolepropionic acid has been shown to prevent oxidative stress and death of primary neurons and neuroblastoma cells exposed to the amyloid beta-protein in the form of amyloid fibrils, one of the most prominent neuropathologic features of Alzheimer's disease. 3-Indolepropionic acid also shows a strong level of neuroprotection in two other paradigms of oxidative stress. (PMID 10419516) ... More recently it has been found that higher indole-3-propionic acid levels in serum/plasma are associated with reduced likelihood of type 2 diabetes and with higher levels of consumption of fiber-rich foods (PMID 28397877)
Origin: • Endogenous • Microbial" - ↑ "Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid". J. Biol. Chem. 274 (31): 21937–21942. July 1999. doi:10.1074/jbc.274.31.21937. PMID 10419516. "[Indole-3-propionic acid (IPA)] has previously been identified in the plasma and cerebrospinal fluid of humans, but its functions are not known. ... In kinetic competition experiments using free radical-trapping agents, the capacity of IPA to scavenge hydroxyl radicals exceeded that of melatonin, an indoleamine considered to be the most potent naturally occurring scavenger of free radicals. In contrast with other antioxidants, IPA was not converted to reactive intermediates with pro-oxidant activity.".
- ↑ Tan, CK; Wu YP; Wu HY; Lai CC (August 2008). "Purple urine bag syndrome". Canadian Medical Association Journal 179 (5): 491. doi:10.1503/cmaj.071604. PMID 18725621.
- ↑ Evenepoel, P; Meijers, BK; Bammens, BR; Verbeke, K (December 2009). "Uremic toxins originating from colonic microbial metabolism.". Kidney International Supplements 76 (114): S12-9. doi:10.1038/ki.2009.402. PMID 19946322.
 |  |
